6
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
June 30, 2008
LY6K, VEGFR1, VEGFR2
1 mg/body every two week with GM-CSF, 4 cycles
Takuya Takayama M.D.Ph.D, Tokyo
Human Genome Center, Institute of Medical Science, University of Tokyo
OTHER
Japanese Foundation for Cancer Research
OTHER